Company / Assets per Share
Inmune Bio, Inc. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.45
FY2025
5-year range
$1.45 / $7.41
FY2021-FY2025
Trend
-34.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has declined for 4 consecutive years, from $7.41 in FY2021 to $1.45 in FY2025.
Based on SEC 10-K filings.
1.45 in FY2025 with a 5-year CAGR of -17.4%.
Declined from $3.18 to $1.45 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -31.8%
- 5-Year CAGR
- -17.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Inmune Bio, Inc.'s assets per share has declined for 4 consecutive years.
- In FY2025, assets per share decreased 34.1% year-over-year.
- Peak assets per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 49.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.45 | -34.1% |
| FY2024 | $2.20 | -30.6% |
| FY2023 | $3.18 | -30.7% |
| FY2022 | $4.58 | -38.2% |
| FY2021 | $7.41 | +96.4% |
| FY2020 | $3.77 | +80.9% |
| FY2018 | $2.09 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026